Sandra Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sandra Torres has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Daniel Carneiro
Unit of Experimental Biology, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
3 shared publications - Isaura Tavares
Unit of Experimental Biology, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
2 shared publications André Magalhães
Breast Center, Centro Hospitalar Universitário de São João, Porto, Portugal
1 shared publicationBárbara Peleteiro
Faculdade de Medicina da Universidade do Porto, Porto, Portugal
1 shared publication- Daniel Humberto Pozza
Unit of Experimental Biology, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
1 shared publication - Daniela Santos-Faria
Unidade Local Saude Alto Minho, Serv Reumatol, Ponte do Lima, Portugal
1 shared publication
Latest Publications
- Open Access
Chronic Pain in Older Adults: Risk Factors and Prevention
Chronic pain is highly prevalent among older adults and represents a major health challenge due to its multifactorial aetiology, association with multimorbidity and frailty, and impact on quality of life. This narrative review synthesises evidence from the last few decades addressing chronic pain in older adults, with emphasis on risk factors, underlying mechanisms, and preventive strategies. Risk factors were organised according to the Dahlgren and Whitehead “Rainbow model” into individual, environmental, and social determinants. Individual-level factors—particularly physical inactivity, abnormal body weight, poor nutrition, mental health disorders, maladaptive pain beliefs, sleep disturbance, previous surgical and postoperative pain, multimorbidity, frailty, smoking, and alcohol use—were associated with pain persistence. Emerging evidence related to environmental and social determinants, including reduced nature and sunlight exposure, low socio-economic status, occupational factors, and social isolation, suggests further increased pain vulnerability. Mechanistic evidence indicates that ageing is associated with impaired descending pain modulation and increased susceptibility to peripheral and central sensitisation. Although randomised preventive trials in older adults remain scarce, converging evidence suggests that targeted lifestyle modification, early pain management, and multimodal non-pharmacological strategies may reduce progression to chronic pain. A prevention-oriented, risk-stratified approach integrating clinical care with broader public health strategies may help mitigate the growing burden of chronic pain in ageing societies.
Open AccessChronic Pain in Older Adults: Risk Factors and Prevention
Chronic pain is highly prevalent among older adults and represents a major health challenge due to its multifactorial aetiology, association with multimorbidity and frailty, and impact on quality of life. This narrative review synthesises evidence from the last few decades addressing chronic pain in older adults, with emphasis on risk factors, underlying mechanisms, and preventive strategies. Risk factors were organised according to the Dahlgren and Whitehead “Rainbow model” into individual, environmental, and social determinants. Individual-level factors—particularly physical inactivity, abnormal body weight, poor nutrition, mental health disorders, maladaptive pain beliefs, sleep disturbance, previous surgical and postoperative pain, multimorbidity, frailty, smoking, and alcohol use—were associated with pain persistence. Emerging evidence related to environmental and social determinants, including reduced nature and sunlight exposure, low socio-economic status, occupational factors, and social isolation, suggests further increased pain vulnerability. Mechanistic evidence indicates that ageing is associated with impaired descending pain modulation and increased susceptibility to peripheral and central sensitisation. Although randomised preventive trials in older adults remain scarce, converging evidence suggests that targeted lifestyle modification, early pain management, and multimodal non-pharmacological strategies may reduce progression to chronic pain. A prevention-oriented, risk-stratified approach integrating clinical care with broader public health strategies may help mitigate the growing burden of chronic pain in ageing societies.
- Open Access
- 1 March 2026
- Published by Wolters Kluwer Health in RISE Health Research Journal
- Vol. 11 (2)
Balneotherapy for pain in fibromyalgia: is there evidence to support subsidized therapy in Portugal? An evidence-based review
Fibromyalgia (FM) is a chronic condition characterized by widespread pain, fatigue, mood, and sleep disturbances, predominantly affecting women. Treatment includes pharmacological and non-pharmacological approaches, such as balneotherapy (BT). This review evaluated the evidence on the effectiveness of BT in managing FM-related pain and its potential inclusion for reimbursement by the Portuguese National Health Service. We systematically searched clinical guidelines, systematic reviews, meta-analyses, and randomized controlled trials (2004–2024). The inclusion criteria followed the PICO model: adults with FM, BT, or hydrotherapy interventions, comparison with education or other therapies, and outcomes related to pain improvement. Of 234 articles identified, nine met the criteria. The European League Against Rheumatism (EULAR) recommends BT as an adjunctive treatment, and meta-analyses and clinical trials consistently demonstrate its effectiveness. BT was associated with significant pain reduction (standardized mean difference −0.8 to −1.8) with benefits lasting 3–6 months and only mild, transient adverse events. These findings suggest that BT is a safe and clinically effective adjunctive intervention for pain management in fibromyalgia, supporting consideration for inclusion among reimbursed indications in Portugal (strength of recommendation A).
- 1 March 2026
- Published by Wolters Kluwer Health in RISE Health Research Journal
- Vol. 11 (2)
Open AccessBalneotherapy for pain in fibromyalgia: is there evidence to support subsidized therapy in Portugal? An evidence-based review
Fibromyalgia (FM) is a chronic condition characterized by widespread pain, fatigue, mood, and sleep disturbances, predominantly affecting women. Treatment includes pharmacological and non-pharmacological approaches, such as balneotherapy (BT). This review evaluated the evidence on the effectiveness of BT in managing FM-related pain and its potential inclusion for reimbursement by the Portuguese National Health Service. We systematically searched clinical guidelines, systematic reviews, meta-analyses, and randomized controlled trials (2004–2024). The inclusion criteria followed the PICO model: adults with FM, BT, or hydrotherapy interventions, comparison with education or other therapies, and outcomes related to pain improvement. Of 234 articles identified, nine met the criteria. The European League Against Rheumatism (EULAR) recommends BT as an adjunctive treatment, and meta-analyses and clinical trials consistently demonstrate its effectiveness. BT was associated with significant pain reduction (standardized mean difference −0.8 to −1.8) with benefits lasting 3–6 months and only mild, transient adverse events. These findings suggest that BT is a safe and clinically effective adjunctive intervention for pain management in fibromyalgia, supporting consideration for inclusion among reimbursed indications in Portugal (strength of recommendation A).
- Open Access
- 25 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (21) , 2702
Descending Pain Modulation in Fibromyalgia: A Short Review of Mechanisms and Biomarkers
Fibromyalgia is a prevalent chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and sleep disturbances, with high impact in quality of life. Despite extensive research, the pathophysiological mechanisms of fibromyalgia remain partially understood, complicating the diagnosis and treatment. Some evidence underscores the central role of abnormal pain processing, particularly central sensitization and defective descending pain modulation pathways. This review synthesizes and discusses current findings on the neurobiological underpinnings of pain in fibromyalgia, with focus on descending inhibitory control mechanisms and on the role of biomarkers. We integrate data from neurochemical, neuroimaging, and clinical studies to explain how impaired descending modulation contributes to enhanced pain sensitivity and discuss the putative biomarkers associated with changes in descending modulation. A better understanding of descending pain modulation dysfunction in fibromyalgia and related biomarkers is crucial for improving clinical outcomes and developing novel and more effective treatments.
- 25 October 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (21) , 2702
Open AccessDescending Pain Modulation in Fibromyalgia: A Short Review of Mechanisms and Biomarkers
Fibromyalgia is a prevalent chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and sleep disturbances, with high impact in quality of life. Despite extensive research, the pathophysiological mechanisms of fibromyalgia remain partially understood, complicating the diagnosis and treatment. Some evidence underscores the central role of abnormal pain processing, particularly central sensitization and defective descending pain modulation pathways. This review synthesizes and discusses current findings on the neurobiological underpinnings of pain in fibromyalgia, with focus on descending inhibitory control mechanisms and on the role of biomarkers. We integrate data from neurochemical, neuroimaging, and clinical studies to explain how impaired descending modulation contributes to enhanced pain sensitivity and discuss the putative biomarkers associated with changes in descending modulation. A better understanding of descending pain modulation dysfunction in fibromyalgia and related biomarkers is crucial for improving clinical outcomes and developing novel and more effective treatments.
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 10 (5)
Benzodiazepine use in hospitalized older adults: a retrospective observational study
Background: To assess the prevalence and indications for the use of benzodiazepines (BZDs) in patients admitted to an acute geriatric unit and to evaluate changes in their prescriptions. Methods: BZD indications were investigated using computerized clinical records. Changes in BZD prescriptions were assessed at the time of discharge. Results: Among the 165 patients included (mean age: 86.7 years, 71.5% women), 60 (36.4%) were taking BZD on admission, 58.3% of which were considered inappropriate. At discharge, BZD discontinuation was observed in 11.7% and dose reduction was initiated in 18.3%. Conclusions: Most patients using BZD had no clear medical indication. Admission to a geriatric ward resulted in successful discontinuation or dose reduction in a third of patients.
- 1 September 2025
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 10 (5)
Open AccessBenzodiazepine use in hospitalized older adults: a retrospective observational study
Background: To assess the prevalence and indications for the use of benzodiazepines (BZDs) in patients admitted to an acute geriatric unit and to evaluate changes in their prescriptions. Methods: BZD indications were investigated using computerized clinical records. Changes in BZD prescriptions were assessed at the time of discharge. Results: Among the 165 patients included (mean age: 86.7 years, 71.5% women), 60 (36.4%) were taking BZD on admission, 58.3% of which were considered inappropriate. At discharge, BZD discontinuation was observed in 11.7% and dose reduction was initiated in 18.3%. Conclusions: Most patients using BZD had no clear medical indication. Admission to a geriatric ward resulted in successful discontinuation or dose reduction in a third of patients.
- Open Access
- 27 March 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (10) , 7529-7538
Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance
Purpose: Women with BRCA1 and BRCA2 (BRCA1/2) pathogenic/likely pathogenic (P/LP) variants have a higher risk to develop breast and ovarian cancer. In structured high-risk clinics, risk-reducing measures are adopted. This study aimed at characterizing these women and identify factors that may have influenced their choice between risk reduction mastectomy (RRM) and intensive breast surveillance (IBS). Methods: This study reviewed retrospectively 187 clinical records of affected and unaffected women with P/LP variants of the BRCA1/2 genes, from 2007 to 2022, of which 50 chose RRM, while 137 chose IBS. The research focused on personal and family history and tumor characteristics and their relation with the preventive option chosen. Results: Among women with personal history of breast cancer, a higher proportion opted for RRM compared to those asymptomatic (34.2% vs 21.3%, p = 0.049), with younger age determining the option for RRM (38.5 years vs 44.0 years, p < 0.001). Among women with personal history of ovarian cancer, a higher proportion opted for RRM compared to those without that history (62.5% vs 25.1%, p = 0.033), with younger age determining the option for RRM (42.6 years vs 62.7 years, p = 0.009). Women who had bilateral salpingo-oophorectomy were more likely to choose RRM than those who did not (37.3% vs 18.3%, p = 0.003). Family history was not associated with preventive option (33.3% vs 25.3, p = 0.346). Conclusions: The decision for the preventive option is multifactorial. In our study, personal history of breast or ovarian cancer, younger age at diagnosis, and previous bilateral salpingo-oophorectomy were associated with the choice of RRM. Family history was not associated with the preventive option.
- 27 March 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (10) , 7529-7538
Open AccessDifferences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance
Purpose: Women with BRCA1 and BRCA2 (BRCA1/2) pathogenic/likely pathogenic (P/LP) variants have a higher risk to develop breast and ovarian cancer. In structured high-risk clinics, risk-reducing measures are adopted. This study aimed at characterizing these women and identify factors that may have influenced their choice between risk reduction mastectomy (RRM) and intensive breast surveillance (IBS). Methods: This study reviewed retrospectively 187 clinical records of affected and unaffected women with P/LP variants of the BRCA1/2 genes, from 2007 to 2022, of which 50 chose RRM, while 137 chose IBS. The research focused on personal and family history and tumor characteristics and their relation with the preventive option chosen. Results: Among women with personal history of breast cancer, a higher proportion opted for RRM compared to those asymptomatic (34.2% vs 21.3%, p = 0.049), with younger age determining the option for RRM (38.5 years vs 44.0 years, p < 0.001). Among women with personal history of ovarian cancer, a higher proportion opted for RRM compared to those without that history (62.5% vs 25.1%, p = 0.033), with younger age determining the option for RRM (42.6 years vs 62.7 years, p = 0.009). Women who had bilateral salpingo-oophorectomy were more likely to choose RRM than those who did not (37.3% vs 18.3%, p = 0.003). Family history was not associated with preventive option (33.3% vs 25.3, p = 0.346). Conclusions: The decision for the preventive option is multifactorial. In our study, personal history of breast or ovarian cancer, younger age at diagnosis, and previous bilateral salpingo-oophorectomy were associated with the choice of RRM. Family history was not associated with the preventive option.